China Intravenous (IV) Solutions Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Intravenous (IV) Solutions market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Intravenous (IV) Solutions market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous (IV) Solutions industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Grifols SA (Spain)

    • B Braun Melsungen AG (Germany)

    • Baxter (US)

    • Terumo Medical Corporation (Tokyo)

    • ICU Medical Inc (US)

    • Amanta Healthcare (India)

    • Fresenius Kabi AG (Germany)

    By Type:

    • Peripheral Parenteral Nutrition

    • Total Parenteral Nutrition

    By End-User:

    • Hospital & Clinics

    • Ambulatory

    • Home Care

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous (IV) Solutions Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Intravenous (IV) Solutions Market Size and Growth Rate of Peripheral Parenteral Nutrition from 2016 to 2027

    • 1.3.2 China Intravenous (IV) Solutions Market Size and Growth Rate of Total Parenteral Nutrition from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Intravenous (IV) Solutions Market Size and Growth Rate of Hospital & Clinics from 2016 to 2027

    • 1.4.2 China Intravenous (IV) Solutions Market Size and Growth Rate of Ambulatory from 2016 to 2027

    • 1.4.3 China Intravenous (IV) Solutions Market Size and Growth Rate of Home Care from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Intravenous (IV) Solutions Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous (IV) Solutions by Major Types

    • 3.4.1 Market Size and Growth Rate of Peripheral Parenteral Nutrition

    • 3.4.2 Market Size and Growth Rate of Total Parenteral Nutrition

    4 Segmentation of Intravenous (IV) Solutions Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous (IV) Solutions by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Intravenous (IV) Solutions in Hospital & Clinics

    • 4.4.2 Market Size and Growth Rate of Intravenous (IV) Solutions in Ambulatory

    • 4.4.3 Market Size and Growth Rate of Intravenous (IV) Solutions in Home Care

    5 Market Analysis by Regions

    • 5.1 China Intravenous (IV) Solutions Production Analysis by Regions

    • 5.2 China Intravenous (IV) Solutions Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Intravenous (IV) Solutions Landscape Analysis

    • 6.1 North China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 6.2 North China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    7 Central China Intravenous (IV) Solutions Landscape Analysis

    • 7.1 Central China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 7.2 Central China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    8 South China Intravenous (IV) Solutions Landscape Analysis

    • 8.1 South China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 8.2 South China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    9 East China Intravenous (IV) Solutions Landscape Analysis

    • 9.1 East China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 9.2 East China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    10 Northeast China Intravenous (IV) Solutions Landscape Analysis

    • 10.1 Northeast China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 10.2 Northeast China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    11 Southwest China Intravenous (IV) Solutions Landscape Analysis

    • 11.1 Southwest China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 11.2 Southwest China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    12 Northwest China Intravenous (IV) Solutions Landscape Analysis

    • 12.1 Northwest China Intravenous (IV) Solutions Landscape Analysis by Major Types

    • 12.2 Northwest China Intravenous (IV) Solutions Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Grifols SA (Spain)

      • 13.1.1 Grifols SA (Spain) Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 B Braun Melsungen AG (Germany)

      • 13.2.1 B Braun Melsungen AG (Germany) Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Baxter (US)

      • 13.3.1 Baxter (US) Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Terumo Medical Corporation (Tokyo)

      • 13.4.1 Terumo Medical Corporation (Tokyo) Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 ICU Medical Inc (US)

      • 13.5.1 ICU Medical Inc (US) Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Amanta Healthcare (India)

      • 13.6.1 Amanta Healthcare (India) Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Fresenius Kabi AG (Germany)

      • 13.7.1 Fresenius Kabi AG (Germany) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Intravenous (IV) Solutions Market Size and Growth Rate of Peripheral Parenteral Nutrition from 2016 to 2027

    • Figure China Intravenous (IV) Solutions Market Size and Growth Rate of Total Parenteral Nutrition from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Intravenous (IV) Solutions Market Size and Growth Rate of Hospital & Clinics from 2016 to 2027

    • Figure China Intravenous (IV) Solutions Market Size and Growth Rate of Ambulatory from 2016 to 2027

    • Figure China Intravenous (IV) Solutions Market Size and Growth Rate of Home Care from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Intravenous (IV) Solutions Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Intravenous (IV) Solutions Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Intravenous (IV) Solutions

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous (IV) Solutions by Different Types from 2016 to 2027

    • Table Consumption Share of Intravenous (IV) Solutions by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Peripheral Parenteral Nutrition

    • Figure Market Size and Growth Rate of Total Parenteral Nutrition

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Intravenous (IV) Solutions by Different End-Users from 2016 to 2027

    • Table Consumption Share of Intravenous (IV) Solutions by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital & Clinics

    • Figure Market Size and Growth Rate of Ambulatory

    • Figure Market Size and Growth Rate of Home Care

    • Table China Intravenous (IV) Solutions Production by Regions

    • Table China Intravenous (IV) Solutions Production Share by Regions

    • Figure China Intravenous (IV) Solutions Production Share by Regions in 2016

    • Figure China Intravenous (IV) Solutions Production Share by Regions in 2021

    • Figure China Intravenous (IV) Solutions Production Share by Regions in 2027

    • Table China Intravenous (IV) Solutions Consumption by Regions

    • Table China Intravenous (IV) Solutions Consumption Share by Regions

    • Figure China Intravenous (IV) Solutions Consumption Share by Regions in 2016

    • Figure China Intravenous (IV) Solutions Consumption Share by Regions in 2021

    • Figure China Intravenous (IV) Solutions Consumption Share by Regions in 2027

    • Table North China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table North China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure North China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure North China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure North China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table North China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table North China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure North China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure North China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure North China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table Central China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table Central China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure Central China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure Central China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure Central China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table Central China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table Central China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure Central China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure Central China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table South China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table South China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure South China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure South China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure South China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table South China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table South China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure South China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure South China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure South China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table East China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table East China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure East China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure East China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure East China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table East China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table East China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure East China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure East China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure East China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table Northeast China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table Northeast China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table Northeast China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table Northeast China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure Northeast China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table Southwest China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table Southwest China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table Southwest China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table Southwest China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure Southwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table Northwest China Intravenous (IV) Solutions Consumption by Types from 2016 to 2027

    • Table Northwest China Intravenous (IV) Solutions Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by Types in 2016

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by Types in 2021

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by Types in 2027

    • Table Northwest China Intravenous (IV) Solutions Consumption by End-Users from 2016 to 2027

    • Table Northwest China Intravenous (IV) Solutions Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2016

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2021

    • Figure Northwest China Intravenous (IV) Solutions Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Grifols SA (Spain)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols SA (Spain)

    • Figure Sales and Growth Rate Analysis of Grifols SA (Spain)

    • Figure Revenue and Market Share Analysis of Grifols SA (Spain)

    • Table Product and Service Introduction of Grifols SA (Spain)

    • Table Company Profile and Development Status of B Braun Melsungen AG (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B Braun Melsungen AG (Germany)

    • Figure Sales and Growth Rate Analysis of B Braun Melsungen AG (Germany)

    • Figure Revenue and Market Share Analysis of B Braun Melsungen AG (Germany)

    • Table Product and Service Introduction of B Braun Melsungen AG (Germany)

    • Table Company Profile and Development Status of Baxter (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter (US)

    • Figure Sales and Growth Rate Analysis of Baxter (US)

    • Figure Revenue and Market Share Analysis of Baxter (US)

    • Table Product and Service Introduction of Baxter (US)

    • Table Company Profile and Development Status of Terumo Medical Corporation (Tokyo)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Medical Corporation (Tokyo)

    • Figure Sales and Growth Rate Analysis of Terumo Medical Corporation (Tokyo)

    • Figure Revenue and Market Share Analysis of Terumo Medical Corporation (Tokyo)

    • Table Product and Service Introduction of Terumo Medical Corporation (Tokyo)

    • Table Company Profile and Development Status of ICU Medical Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICU Medical Inc (US)

    • Figure Sales and Growth Rate Analysis of ICU Medical Inc (US)

    • Figure Revenue and Market Share Analysis of ICU Medical Inc (US)

    • Table Product and Service Introduction of ICU Medical Inc (US)

    • Table Company Profile and Development Status of Amanta Healthcare (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amanta Healthcare (India)

    • Figure Sales and Growth Rate Analysis of Amanta Healthcare (India)

    • Figure Revenue and Market Share Analysis of Amanta Healthcare (India)

    • Table Product and Service Introduction of Amanta Healthcare (India)

    • Table Company Profile and Development Status of Fresenius Kabi AG (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi AG (Germany)

    • Figure Sales and Growth Rate Analysis of Fresenius Kabi AG (Germany)

    • Figure Revenue and Market Share Analysis of Fresenius Kabi AG (Germany)

    • Table Product and Service Introduction of Fresenius Kabi AG (Germany)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.